PPBT - PURPLE BIOTECH LTD.

QQQ $ 441.71 $ 1.04 (0.24 %)

DIA $ 395.04 $ 1.18 (0.3 %)

SPY $ 520.76 $ 0.67 (0.13 %)

TLT $ 90.14 $ -0.51 (-0.56 %)

GLD $ 218.73 $ 1.76 (0.81 %)

Previous Close

$ 0.5251

Open

$ 0.51

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 0.51 - $ 0.53

52 Week Range

$ 0.30 - $ 1.99

Volume

68,345

Average Volume

Market Cap

13.25M

Beta (5Y Monthly)

$ 1.11

PE Ratio (TTM)

$ 1.23

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
No Data found

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

12-health-care-stocks-moving-in-fridays-after-market-session

12 Health Care Stocks Moving In Friday's A...
05/10/2024 20:31:10

HC Wainwright & Co. Reiterates Buy on Purp...
04/26/2024 18:24:25

HC Wainwright & Co. analyst Emily Bodnar reiterates Purple Biotech (NASDAQ:PPBT) with a Buy and maintains $10 price target.

Purple Biotech Says Randomized Phase 2 CM2...
04/25/2024 11:25:46

12-health-care-stocks-moving-in-mondays-after-market-session

12 Health Care Stocks Moving In Monday's A...
04/22/2024 20:31:12

Purple Biotech Reported Preclinical Proof ...
03/14/2024 11:35:38

Chardan Capital Maintains Buy on Purple Bi...
03/07/2024 18:56:09

Chardan Capital analyst Daniil Gataulin maintains Purple Biotech (NASDAQ:PPBT) with a Buy and maintains $11 price target.

HC Wainwright & Co. Reiterates Buy on Purp...
03/05/2024 17:07:53

HC Wainwright & Co. analyst Emily Bodnar reiterates Purple Biotech (NASDAQ:PPBT) with a Buy and maintains $10 price target.

Purple Biotech Q4 EPS $(0.19), Inline
03/05/2024 12:58:32

Purple Biotech (NASDAQ:PPBT) reported quarterly losses of $(0.19) per share which met the analyst consensus estimate. This is a...

HC Wainwright & Co. Reiterates Buy on Purp...
02/27/2024 17:46:24

HC Wainwright & Co. analyst Emily Bodnar reiterates Purple Biotech (NASDAQ:PPBT) with a Buy and maintains $10 price target.

Purple Biotech Says Determined 100Mg/Kg Is...
02/01/2024 12:38:16

NT219 is a first-in-class small molecule dual inhibitor of IRS1/2 and STAT3. The Phase 1 dose escalation study is being conclud...

12-health-care-stocks-moving-in-wednesdays-after-market-session

12 Health Care Stocks Moving In Wednesday'...
01/10/2024 21:31:09

Purple Biotech Says It Completed Patient E...
12/14/2023 11:53:27

12-health-care-stocks-moving-in-mondays-pre-market-session

12 Health Care Stocks Moving In Monday's P...
12/11/2023 13:06:40

why-green-giant-shares-are-trading-lower-by-around-37-here-are-20-stocks-moving-premarket

Why Green Giant Shares Are Trading Lower B...
12/11/2023 12:59:28

Shares of Green Giant Inc. (NASDAQ: GGE) fell sharply in pre-market trading after announcing a proposed public offering. Gre...

HC Wainwright & Co. Maintains Buy on Purpl...
11/21/2023 18:45:31

HC Wainwright & Co. analyst Emily Bodnar maintains Purple Biotech (NASDAQ:PPBT) with a Buy and raises the price target f...

Purple Biotech: Q3 Earnings Insights
11/21/2023 12:00:06

Purple Biotech Q3 EPS $(0.23), Inline; $15...
11/21/2023 11:56:13

Purple Biotech (NASDAQ:PPBT) reported quarterly losses of $(0.23) per share which met the analyst consensus estimate. This is a...

12-health-care-stocks-moving-in-tuesdays-pre-market-session

12 Health Care Stocks Moving In Tuesday's ...
10/17/2023 13:06:03

Purple Biotech Announces $5M Registered Di...
10/17/2023 12:08:38

12 Health Care Stocks Moving In Friday's A...
10/13/2023 21:31:42